About the H1N1 Vaccines Market
The high level of maturity in the H1N1 vaccines market has renewed the push to develop quadrivalent vaccines that address areas of the market with unmet medical needs. Vaccines that prevent H1N1 have been a long-standing void in the treatment algorithm. Therefore, the introduction advanced vaccines in the next decade will likely alter the global H1N1 vaccines market landscape. Sanofi, AstraZeneca, and VaxInnate have also invested in quadrivalent vaccines, such as Sanofi's VaxiGrip, VaxInnate's VAX2012Q, and AstraZeneca's MEDI-550 vaccine, which will impact the US and Europe markets during the forecast period. Other areas of opportunity for novel entrants include vaccines with improved immune response and immunogenic infant vaccines.
Technavio’s analysts forecast the global H1N1 vaccines market to grow at a CAGR of 4.17% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global H1N1 vaccines market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of vaccines used to prevent H1N1 infection. The report also considers the revenues to be generated from the sales of vaccines that are expected to be launched into the market during the forecast period.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global H1N1 Vaccines Market 2016-2020
Technavio recognizes the following companies as the key players in the global H1N1 vaccines market: Sanofi, GSK, Astra Zeneca, and CSL.
Other Prominent Vendors in the market are: Abbott, Baxter International, CEL-SCI, Cipla, Crucell, Denka Seiken, Green Cross, Hualan Biological Engineering, iBio, Imunoloski Zavod, Inovio Biomedical, Lupin, Medicago USA, Merck, Mitsubishi Tanabe Pharma, Omnivest, Panacea, Pfizer, Protein Sciences, Serum Institute of India, Sinovac Biotech, Solvay, Zhejiang Tianyuan Bio-pharmaceuticals, and Zydus Cadila.
Commenting on the report, an analyst from Technavio’s team said: “One trend that is boosting market growth is an improved understanding of immunology. Technological advances and improved understanding of immunology and immunotherapy have enabled the discovery of biomarkers. This has aided in developing therapy through natural body defense mechanisms. Therapeutic vaccines that are capable of inducing the immune system to attack the targeted diseased tissue with greater bioavailability and specificity and minimal side effects associated with therapeutic drugs are being developed. Therapeutic vaccines are considered as viable alternatives to the existing therapeutic approaches.”
According to the report, a key growth driver is the global action plan for influenza vaccines. In a 2006 consultation, WHO, in collaboration with vaccine manufacturers, academic experts, public health organizations and funding agencies from developed and developing countries, developed the global action plan for influenza vaccines. The plan was intended to combat the global shortage of seasonal epidemic influenza vaccines and pandemic influenza vaccines. It is a comprehensive strategy focused on the increase in seasonal vaccine use and vaccine production capacity, and R&D for influenza vaccines. WHO is working to promote the use of influenza vaccines by encouraging its member states to develop a policy for influenza vaccination. Further, the organization is strengthening global surveillance systems to accurately analyze the circulating strains of influenza virus and determine the global burden of disease.
Further, the report states that one challenge that is hampering market growth is vaccine storage and handling issues. Inadequately stored vaccines lose their effectiveness to protect against diseases and can cause increased local reactions.
Sanofi, GSK, Astra Zeneca, CSL, Abbott, Baxter International, CEL-SCI, Cipla, Crucell, Denka Seiken, Green Cross, Hualan Biological Engineering, iBio, Imunoloski Zavod, Inovio Biomedical, Lupin, Medicago USA, Merck, Mitsubishi Tanabe Pharma, Omnivest, Panacea, Pfizer, Protein Sciences, Serum Institute of India, Sinovac Biotech, Solvay, Zhejiang Tianyuan Bio-pharmaceuticals, Zydus Cadila.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook